Pages that link to "Q35556102"
Jump to navigation
Jump to search
The following pages link to A glance at adenosine receptors: novel target for antitumor therapy (Q35556102):
Displaying 50 items.
- Purinergic signalling and cancer (Q24618782) (← links)
- Anticancer effect of adenosine on gastric cancer via diverse signaling pathways (Q26780305) (← links)
- Emerging adenosine receptor agonists (Q28249111) (← links)
- The reno-vascular A2B adenosine receptor protects the kidney from ischemia (Q28473410) (← links)
- The anti-tumor effect of A3 adenosine receptors is potentiated by pulsed electromagnetic fields in cultured neural cancer cells (Q28728011) (← links)
- Ferrocenes as potential chemotherapeutic drugs: synthesis, cytotoxic activity, reactive oxygen species production and micronucleus assay (Q30882588) (← links)
- CD73 on tumor cells impairs antitumor T-cell responses: a novel mechanism of tumor-induced immune suppression (Q33533705) (← links)
- An In Vivo Gain-of-Function Screen Identifies the Williams-Beuren Syndrome Gene GTF2IRD1 as a Mammary Tumor Promoter (Q33623668) (← links)
- Adenosine A1 receptor, a target and regulator of estrogen receptoralpha action, mediates the proliferative effects of estradiol in breast cancer (Q33690360) (← links)
- Immunity, inflammation and cancer: a leading role for adenosine (Q34038901) (← links)
- Vascular CD39/ENTPD1 directly promotes tumor cell growth by scavenging extracellular adenosine triphosphate (Q34633667) (← links)
- Modulation of A1 and A2B adenosine receptor activity: a new strategy to sensitise glioblastoma stem cells to chemotherapy (Q34662274) (← links)
- Adenosine A1 receptors promote vasa vasorum endothelial cell barrier integrity via Gi and Akt-dependent actin cytoskeleton remodeling (Q34683611) (← links)
- Selective human adenosine A3 antagonists based on pyrido[2,1-f]purine-2,4-diones: novel features of hA3 antagonist binding. (Q34713557) (← links)
- Human breast cancer cell line MDA-MB-231 expresses endogenous A2B adenosine receptors mediating a Ca2+ signal. (Q35048860) (← links)
- Adenosine A2b receptor promotes progression of human oral cancer (Q35728866) (← links)
- First joint Italian-German purine club meeting "Progress in Purinergic Receptor Pharmacology and Function". (Q36173791) (← links)
- Growth regulation of the vascular system: an emerging role for adenosine (Q36193019) (← links)
- Adenosine Stimulate Proliferation and Migration in Triple Negative Breast Cancer Cells (Q36212073) (← links)
- Antrodia camphorata Grown on Germinated Brown Rice Suppresses Melanoma Cell Proliferation by Inducing Apoptosis and Cell Differentiation and Tumor Growth (Q36682649) (← links)
- Adenosine as an endogenous immunoregulator in cancer pathogenesis: where to go? (Q36821572) (← links)
- Host A(2B) adenosine receptors promote carcinoma growth (Q36840284) (← links)
- Modulation of the Akt/Ras/Raf/MEK/ERK pathway by A₃ adenosine receptor (Q37135531) (← links)
- Extracellular ATP and cancer: an overview with special reference to P2 purinergic receptors. (Q37198990) (← links)
- Adenosine receptors and cancer. (Q37565200) (← links)
- High expression of ecto-nucleotidases CD39 and CD73 in human endometrial tumors (Q37636282) (← links)
- Therapeutic potential of adenosine receptor antagonists and agonists (Q37689793) (← links)
- Adenosine receptor targeting in health and disease (Q37948081) (← links)
- Therapeutic potential of A2 and A3 adenosine receptor: a review of novel patented ligands (Q37995704) (← links)
- Immunoregulatory activity of adenosine and its role in human cancer progression (Q38215678) (← links)
- Adenosine A2A and A2B receptor expression in neuroendocrine tumours: potential targets for therapy (Q38406861) (← links)
- The effect of adenosine A1 receptor agonist and antagonist on p53 and caspase 3, 8, and 9 expression and apoptosis rate in MCF-7 breast cancer cell line (Q38744576) (← links)
- Role of adenosine signaling in the pathogenesis of breast cancer. (Q39224357) (← links)
- Adenosine: An endogenous mediator in the pathogenesis of gynecological cancer (Q39375802) (← links)
- A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy (Q39418010) (← links)
- Alterations in the extracellular catabolism of nucleotides are involved in the antiproliferative effect of quercetin in human bladder cancer T24 cells (Q39433840) (← links)
- P-glycoprotein mediates resistance to A3 adenosine receptor agonist 2-chloro-N6-(3-iodobenzyl)-adenosine-5'-n-methyluronamide in human leukemia cells (Q39552900) (← links)
- A(2B) and A(3) adenosine receptors modulate vascular endothelial growth factor and interleukin-8 expression in human melanoma cells treated with etoposide and doxorubicin. (Q39793029) (← links)
- Differential ectonucleotidase expression in human bladder cancer cell lines (Q39860148) (← links)
- The role of ecto-5'-nucleotidase/CD73 in glioma cell line proliferation (Q39959907) (← links)
- Dexamethasone inhibits proliferation and stimulates ecto-5'-nucleotidase/CD73 activity in C6 rat glioma cell line (Q40142178) (← links)
- Endogenous expression of adenosine A1, A2 and A3 receptors in rat C6 glioma cells. (Q40151032) (← links)
- Adenine nucleotides inhibit proliferation of the human lung adenocarcinoma cell line LXF-289 by activation of nuclear factor kappaB1 and mitogen-activated protein kinase pathways (Q40243474) (← links)
- Crystal structure of bis-[4-(1H-pyrrol-1-yl)phen-yl] ferrocene-1,1'-di-carboxyl-ate: a potential chemotherapeutic drug. (Q40279258) (← links)
- A3 adenosine receptors modulate hypoxia-inducible factor-1alpha expression in human A375 melanoma cells (Q40359398) (← links)
- Pyrazolotriazolopyrimidine derivatives sensitize melanoma cells to the chemotherapic drugs: taxol and vindesine (Q40639053) (← links)
- Adenosine and lymphocyte regulation (Q40729772) (← links)
- Human follicular lymphoma CD39+-infiltrating T cells contribute to adenosine-mediated T cell hyporesponsiveness (Q41849280) (← links)
- Antiinflammatory adaptation to hypoxia through adenosine-mediated cullin-1 deneddylation (Q41872746) (← links)
- Adenosine A3 receptor elicits chemoresistance mediated by multiple resistance-associated protein-1 in human glioblastoma stem-like cells (Q42317561) (← links)